Omada Health Reports Strong Q1 Results, Raises Full-Year Guidance, and Expands GLP-1 Partnerships

summarizeSummary

Omada Health reported strong first-quarter 2026 financial results, including 42% year-over-year revenue growth and positive Adjusted EBITDA, leading to a significant increase in its full-year 2026 guidance for both revenue and Adjusted EBITDA, alongside new strategic GLP-1 partnerships.

check_boxKey Events

• Strong Q1 Financial Performance

  Reported Q1 2026 revenue of $78 million, a 42% increase year-over-year, and achieved positive Adjusted EBITDA of $1 million, compared to a $4 million loss in Q1 2025. Net loss significantly narrowed to $3 million from $9 million.

• Raised Full-Year 2026 Guidance

  Increased full-year 2026 revenue guidance to a range of $322 million to $330 million (up from $312M-$322M) and Adjusted EBITDA guidance to $14 million to $20 million (up from $7M-$15M), reflecting strong operational outlook.

• Expanded GLP-1 Partnerships

  Joined Optum Rx's Weight Engage portfolio and will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program, significantly expanding access to GLP-1 and cardiometabolic care through all three leading PBMs.

• Milestone Member Growth

  Surpassed 1.02 million total members at the end of Q1, representing a 51% increase year-over-year, underscoring the growing adoption of Omada's integrated multi-condition platform.

auto_awesomeAnalysis

Omada Health's first-quarter results demonstrate significant operational and financial momentum, highlighted by robust revenue growth and a shift to positive Adjusted EBITDA. The upward revision of full-year revenue and Adjusted EBITDA guidance signals management's increased confidence in continued performance. Crucially, the expansion of GLP-1 partnerships with Optum Rx and Eli Lilly's Employer Connect program positions Omada Health for substantial growth in the rapidly evolving cardiometabolic and weight management market, significantly broadening its reach to commercially insured lives. This filing confirms the positive news reported earlier today and provides critical forward-looking details.